| MRNAModerna | US$386.51 | 17.7% | 392.6% | US$155.2b | US$187.80 | P/E254.1x | E-56.8% | n/a | |
| PFEPfizer | US$45.68 | 8.5% | 19.0% | US$255.7b | US$43.82 | P/E20.7x | E-2.2% | 3.4% | |
| BNTXBioNTech | US$351.81 | 23.9% | 323.0% | US$85.0b | US$196.10 | P/E59.7x | E-39.3% | n/a | |
| LLYEli Lilly | US$255.99 | 5.1% | 65.3% | US$232.7b | US$241.90 | P/E38.1x | E18.1% | 1.3% | |
| BGNEBeiGene | US$341.10 | 26.7% | 53.2% | US$31.7b | US$384.73 | P/S34.4x | E46.7% | n/a | |
| JNJJohnson & Johnson | US$174.39 | 1.0% | 18.5% | US$459.1b | US$184.35 | P/E25.8x | E9.4% | 2.4% | |
| BMYBristol-Myers Squibb | US$69.31 | 2.7% | 16.5% | US$154.0b | US$76.33 | P/S3.5x | E49.7% | 2.8% | |
| ZLABZai Lab | US$147.52 | 27.2% | 84.4% | US$14.0b | US$214.50 | P/S197.7x | E55.0% | n/a | |
| TMOThermo Fisher Scientific | US$536.99 | 1.3% | 29.2% | US$209.8b | US$572.88 | P/E24.7x | E4.1% | 0.2% | |
| SGENSeagen | US$158.19 | 9.5% | -4.2% | US$28.8b | US$185.17 | P/E47.4x | E70.2% | n/a | |
| ILMNIllumina | US$498.42 | 2.5% | 26.6% | US$72.8b | US$423.68 | P/E116.1x | E24.6% | n/a | |
| PKIPerkinElmer | US$185.17 | 8.8% | 53.3% | US$20.7b | US$176.42 | P/E17.5x | E-8.1% | 0.2% | |
| ICLRICON | US$243.88 | 9.0% | 30.4% | US$19.4b | US$248.62 | P/E35.4x | E19.4% | n/a | |
| CTLTCatalent | US$122.16 | 7.2% | 38.5% | US$20.8b | US$136.70 | P/E40.6x | E9.3% | n/a | |
| IMABI-Mab | US$78.14 | 28.7% | 154.3% | US$6.0b | US$91.75 | P/E62.6x | E-25.2% | n/a | |
| BIOBio-Rad Laboratories | US$746.30 | 6.2% | 41.7% | US$22.0b | US$771.25 | P/E5.5x | E-122.0% | n/a | |
| IQVIQVIA Holdings | US$249.97 | 2.8% | 56.1% | US$47.9b | US$275.21 | P/E78.8x | E25.5% | 0% | |
| RGENRepligen | US$249.07 | 10.0% | 59.1% | US$13.7b | US$254.38 | P/E134.2x | E20.2% | n/a | |
| AAgilent Technologies | US$153.86 | 2.6% | 57.8% | US$46.7b | US$146.31 | P/E51x | E10.5% | 0.5% | |
| CTKBCytek Biosciences | US$26.08 | 48.9% | n/a | US$3.5b | n/a | P/E192.3x | n/a | n/a | |
| TEVATeva Pharmaceutical Industries | US$9.92 | 11.2% | -15.9% | US$10.9b | US$12.21 | P/B1.1x | E34.5% | 0% | |
| GILDGilead Sciences | US$69.83 | 1.3% | -1.5% | US$87.6b | US$75.72 | P/E17x | E6.8% | 4.1% | |
| ZTSZoetis | US$204.10 | 1.1% | 31.1% | US$96.9b | US$204.00 | P/E54.7x | E11.9% | 0.5% | |
| CRLCharles River Laboratories International | US$411.24 | 4.7% | 101.7% | US$20.7b | US$366.14 | P/E54.5x | E18.3% | n/a | |
